نتایج جستجو برای: bcg vaccine

تعداد نتایج: 113591  

2011
S Tafaj G Kasmi

Introduction / objectives The attenuated bacilli Calmette-Guerin (BCG) vaccine is administered in Albania to all newborns at the first day of life to prevent tuberculosis. Although complications are rare after BCG vaccination and the outcome is usually favourable, serious BCG infections can occur. The risks associated with BCG vaccination include local complications, extraregional localized dis...

2012
Hyejon Lee Hazel M. Dockrell Deok Ryun Kim Sian Floyd Sue Yeon Oh Jin Bum Lee Hee Jin Kim

BACKGROUND Delivery of Bacille Calmette-Guréin (BCG) Tokyo vaccine, with the multipuncture device, has been much preferred over BCG Pasteur, with the intradermal method, possibly due to the easier manner of administration, a desire to avoid any trouble with scars, as well as side effects and higher profits to providers in South Korea. METHODS To determine BCG scar status in 0~6 year old child...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2000
M A Horwitz G Harth B J Dillon S Maslesa-Galic'

Tuberculosis (TB) continues to ravage humanity, causing 2 million deaths per year. A vaccine against TB more potent than the current live vaccine, bacillus Calmette-Guérin (BCG), is desperately needed. Using two commercially available strains of BCG as host strains, BCG Connaught and Tice, we have constructed two recombinant BCG vaccines stably expressing and secreting the 30-kDa major secretor...

2013
Shreyash Mehta Pradeep Umrigar Prakash Patel R K Bansal

Results: The overall wastage factor for BCG vaccine was 1.83, for OPV was 1.33, for DPT was 1.19, for Hepatitis B vaccine was 1.26 and for Measles vaccine was 1.39. The WF was highest for sessions held at ICDS for BCG vaccination (3.38) followed by sessions held at mobile sites for BCG vaccination (2.50). The WF was lowest for sessions held at UHC for DPT vaccination (1.11) followed by sessions...

Journal: :Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2010
Alexandra Santos Andrea Dias Ana Cordeiro Carolina Cordinhã Sónia Lemos Graça Rocha Emília Faria

The bacilli Calmette-Guérin (BCG) vaccine is administered to all newborns in countries where tuberculosis is endemic. Immunocompromised hosts, namely patients with human immunodeficiency virus infection or primary immunodeficiencies, are especially prone to serious complications from this vaccine. We report three cases of BCG disease in children with primary immunodeficiencies: one with a parti...

Journal: :Journal of Crohn's & colitis 2010
Kuldeep Cheent Jonathan Nolan Sohail Shariq Liina Kiho Arabinda Pal Jayantha Arnold

We present the case of a 28 year old lady with refractory Crohn's Disease treated with infliximab throughout her pregnancy. Her baby was born healthy and received a Bacillus Calmette-Guérin (BCG) vaccine aged 3 months. Soon after this the infant became unwell and died aged 4.5 months. At post-mortem the cause of death was attributed to an unusual complication of the BCG vaccine, known as dissem...

Journal: :Clinical and vaccine immunology : CVI 2008
D Neil Wedlock Michel Denis Gavin F Painter Gary D Ainge H Martin Vordermeier R Glyn Hewinson Bryce M Buddle

Current efforts are aimed at optimizing the protective efficacy of Mycobacterium bovis BCG by the use of vaccine combinations. We have recently demonstrated that the protection afforded by BCG alone is enhanced by vaccinating cattle with a combination of vaccines comprising BCG and a protein tuberculosis vaccine, namely, culture filtrate proteins (CFPs) from M. bovis plus an adjuvant. In the cu...

2015
Magali Matsumiya Iman Satti Agnieszka Chomka Stephanie A. Harris Lisa Stockdale Joel Meyer Helen A. Fletcher Helen McShane

BACKGROUND Bacillus Calmette-Guerin (BCG) vaccine is the most widely administered vaccine in the world, yet its mechanism of action remains unclear. We hypothesize that certain immune pathways are associated with reduced mycobacterial growth following BCG challenge in human volunteers. METHODS We used samples from a mycobacterial challenge in which previously BCG-vaccinated or BCG-naive adult...

Journal: :JAMA 1994
G A Colditz T F Brewer C S Berkey M E Wilson E Burdick H V Fineberg F Mosteller

OBJECTIVE To quantify the efficacy of BCG vaccine against tuberculosis (TB). DATA SOURCES MEDLINE with index terms BCG vaccine, tuberculosis, and human. Experts from the Centers for Disease Control and Prevention and the World Health Organization, among others, provided lists of all known studies. STUDY SELECTION A total of 1264 articles or abstracts were reviewed for details on BCG vaccina...

2015
Ryan B. Perumpail Aijaz Ahmed John P. Higgins Samuel K. So J. Lynn Cochran Jan Drobeniuc Tonya R. Mixson-Hayden Chong-Gee Teo

based effective treatment (9). Surgical excision remains controversial because of potentially high rates of significant scarring (10). For nonsuppurative lymphadenitis, a watch-and-wait approach is recommended because most resolve rapidly (8). Given our findings, the National TB Program in Georgia subsequently created a management protocol. This protocol recommends no intervention for nonsuppur...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید